Universidad Austral   Report issue

Academic/Hospital Phase 3
Founded: Buenos Aires Argentina (1992)

Organization Overview

First Clinical Trial
2020
NCT04383535
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Austral University, Argentina | Facultad de Ingeniería - Universidad Austral | Universidad Austral

Active Ingredients

Drugs in Phase 3 Trials (2)

l-epigallocatechin (1 trial)

nitazoxanide (Alinia) (1 trial)

Drugs in Other Trials (1)

COVID-19 convalescent plasma (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Infections (Phase 3)

Virus Diseases (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 3